Strategy to Potentiate Rehabilitation after TBI
加强 TBI 后康复的策略
基本信息
- 批准号:10308503
- 负责人:
- 金额:$ 60.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-01 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdultAgonistAnimalsAtrophicBehaviorBehavioralBioenergeticsBrainBrain ConcussionBrain InjuriesBrain imagingBrain-Derived Neurotrophic FactorCellsCellular Metabolic ProcessCerebrovascular CirculationChronicClinicalCognitiveConvalescenceDataDependenceDiffuseDiffusionDiscriminationDoseEarly InterventionElementsExerciseExercise PhysiologyFemaleFlavonoidsFunctional Magnetic Resonance ImagingHippocampus (Brain)ImageImpairmentInjuryInterventionLeadLearningLinkMagnetic Resonance ImagingMapsMeasuresMemoryMetabolic MarkerMetabolismMethodsModelingMolecularMonitorMotor CortexNetwork-basedNeuronsNeurotrophic Tyrosine Kinase Receptor Type 2OutcomePathologicPathologyPatientsPharmacologyPhysical RehabilitationPhysical activityPlayRattusRecoveryRecovery of FunctionRehabilitation OutcomeRehabilitation therapyReportingRestSeveritiesSoldierSwellingSynapsesSynaptic plasticityTBI PatientsTestingTherapeuticTimeTissuesTrainingTraumatic Brain InjuryTraumatic Brain Injury recoveryTreatment Efficacyanxiety-like behaviorbasebehavioral outcomebrain cellbrain metabolismcognitive functionenergy balanceexperienceexperimental studyfunctional outcomesgain of functionimprovedimproved outcomein vivoindexinginsightlimb injurylongitudinal analysismalemetabolic abnormality assessmentmetabolic depressionneural circuitneuronal circuitrynovelpre-clinicalprotein biomarkersrehabilitation strategysmall moleculesuccesssynaptic function
项目摘要
Abstract
Metabolic depression (MD) occurs during the acute period of TBI and this impairs the ability of neuronal circuits
to meet local activity demand, which in turn could limit the success of rehabilitative strategies, and functional
outcome. Although most neurons survive mild or moderate TBI, at least acutely, they cannot operate efficiently
and this severely compromises brain function, which may lead to persistent behavioral deficits. This manifests
as a loss of correlated functional activity using resting state functional magnetic resonance imaging (rsFMRI)
and is typically reported using a connectomic analysis of brain network function. There remains much to learn
about how to treat the injured brain, how the functional trajectory of neurons evolves with time, and the
dependence on the extent and major pathologic subtype of the initial injury. We propose combined rsFMRI,
behavior and molecular studies of metabolism and synaptic plasticity that will provide a longitudinal analysis of
injury to investigate how MD manifests in altered functional connectivity and brain reorganization chronically. We
will use the information gained to provide insight on how the small molecule agonist of TrkB receptors - 7,8-
dihydroxyflavone (DHF) will alter the functional trajectory of the injured brain through reduction of MD acutely,
followed by enhancement of synaptic plasticity and cognitive outcome chronically. By modelling clinical situations
of early post-injury rehabilitation versus rehabilitation that is delayed due to additional injuries, we will determine
whether an intervention with DHF will mitigate the effects of acute MD, followed by, or simultaneously with the
reinstitution of function using a period of early or delayed exercise. We propose studies that will test whether
either intervention, alone or in combination, can be delayed but still provide a significant boost to brain
connectivity and functional outcome. We will conduct these studies in both male and female rats, and will use
new statistically-driven methods that provide a level of confidence to enable subject-level analysis for
discrimination of burden of tissue damage, regardless of the actual injury severity. We will employ these
covariates of MD, tissue swelling and atrophy, as well as exercise level, to derive a statistically robust analysis
of whether off-setting MD acutely, will potentiate the effects of rehabilitation.
抽象的
代谢性抑郁症(MD)发生在TBI的急性期间,这会损害神经元电路的能力
满足当地活动需求,这反过来可能限制康复策略的成功和功能
结果。尽管大多数神经元在轻度或中度的TBI中生存,但至少急性化,它们无法有效运行
这严重损害了大脑功能,这可能导致持续的行为缺陷。这表现出来
作为使用静止状态功能磁共振成像(RSFMRI)的相关功能活性的丧失
并且通常使用大脑网络功能的连接分析进行报告。还有很多要学习的
关于如何治疗受伤的大脑,神经元的功能轨迹如何随着时间的流逝而演变
对初始损伤的程度和主要病理亚型的依赖性。我们提出了RSFMRI的组合,
代谢和突触可塑性的行为和分子研究将提供纵向分析
损伤研究MD如何长期表现在功能连通性和大脑重组中。我们
将使用所获得的信息来洞悉TRKB受体的小分子激动剂-7,8--
二羟基氟氟酮(DHF)将通过急性减少MD,改变受伤大脑的功能轨迹,
然后长期增强突触可塑性和认知结果。通过建模临床情况
由于额外的伤害,我们将确定早期伤害后的康复与康复的康复。
与DHF的干预是否会减轻急性MD的影响,然后与
使用早期或延迟运动时期恢复功能。我们提出的研究将测试是否
干预措施,单独或组合都可以延迟,但仍然可以显着增强大脑
连通性和功能结果。我们将在雄性和雌性大鼠中进行这些研究,并将使用
新的统计驱动方法提供了一定的信心,以实现主题级分析
无论实际伤害严重程度如何,歧视组织损伤负担。我们将采用这些
MD的协变量,组织肿胀和萎缩以及运动水平,以得出统计上强大的分析
偏离脱离MD的MD是否会增强康复的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fernando Gomez-Pinilla其他文献
Fernando Gomez-Pinilla的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fernando Gomez-Pinilla', 18)}}的其他基金
Precision Medicine Approach: Using genomic information to guide TBI treatment
精准医学方法:利用基因组信息指导 TBI 治疗
- 批准号:
10303991 - 财政年份:2021
- 资助金额:
$ 60.31万 - 项目类别:
Precision Medicine Approach: Using genomic information to guide TBI treatment
精准医学方法:利用基因组信息指导 TBI 治疗
- 批准号:
10548225 - 财政年份:2020
- 资助金额:
$ 60.31万 - 项目类别:
Precision Medicine Approach: Using genomic information to guide TBI treatment
精准医学方法:利用基因组信息指导 TBI 治疗
- 批准号:
9916553 - 财政年份:2020
- 资助金额:
$ 60.31万 - 项目类别:
Spatiotemporal Molecular Substrates of TBI at Single Cell Resolution
单细胞分辨率下 TBI 的时空分子底物
- 批准号:
10386933 - 财政年份:2020
- 资助金额:
$ 60.31万 - 项目类别:
Precision Medicine Approach: Using genomic information to guide TBI treatment
精准医学方法:利用基因组信息指导 TBI 治疗
- 批准号:
10084332 - 财政年份:2020
- 资助金额:
$ 60.31万 - 项目类别:
Precision Medicine Approach: Using genomic information to guide TBI treatment
精准医学方法:利用基因组信息指导 TBI 治疗
- 批准号:
10556740 - 财政年份:2020
- 资助金额:
$ 60.31万 - 项目类别:
Strategy to Potentiate Rehabilitation after TBI
加强 TBI 后康复的策略
- 批准号:
10533276 - 财政年份:2020
- 资助金额:
$ 60.31万 - 项目类别:
Spatiotemporal Molecular Substrates of TBI at Single Cell Resolution
单细胞分辨率下 TBI 的时空分子底物
- 批准号:
10200171 - 财政年份:2020
- 资助金额:
$ 60.31万 - 项目类别:
Precision Medicine Approach: Using genomic information to guide TBI treatment
精准医学方法:利用基因组信息指导 TBI 治疗
- 批准号:
10328921 - 财政年份:2020
- 资助金额:
$ 60.31万 - 项目类别:
Spatiotemporal Molecular Substrates of TBI at Single Cell Resolution
单细胞分辨率 TBI 的时空分子底物
- 批准号:
10606498 - 财政年份:2020
- 资助金额:
$ 60.31万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Formation of a functional tendon enthesis during development and healing
在发育和愈合过程中形成功能性肌腱附着点
- 批准号:
10587399 - 财政年份:2023
- 资助金额:
$ 60.31万 - 项目类别:
Microglial process convergence following brain injury
脑损伤后小胶质细胞过程收敛
- 批准号:
10657968 - 财政年份:2023
- 资助金额:
$ 60.31万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 60.31万 - 项目类别:
Fast-kinetics approaches to define direct gene-regulatory functions of MYB in leukemia
快速动力学方法定义 MYB 在白血病中的直接基因调控功能
- 批准号:
10644259 - 财政年份:2023
- 资助金额:
$ 60.31万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 60.31万 - 项目类别: